Featured Industry Insights
Latest Industry Insights
Industry Insight
Raising the Standards of Data Integrity in Modern Research
As the research landscape changes, the standards of data integrity that guide research must also change. New data tools, systems and formats provide pitfalls and opportunities for advancing the cause of data integrity. In this blog, we discuss integrity in modern research with John Sadler, Vice President and General Manager of Agilent’s Software & Informatics Division.
Industry Insight
Accelerating the Development of Organs-on-Chips
Emulate, Inc. and AstraZeneca recently announced they have formed a collaborative partnership which will see Emulate's Organs-on-Chips technology embedded in AstraZeneca's Innovative Medicines and Early Development Biotech Unit.
Industry Insight
AI and Humans: Working Together to Improve Diagnosis
To learn more about the impact AI has already had on diagnostics and health services, as well as some of its future capabilities, we spoke to Chris Scarisbrick.
Industry Insight
Bringing Behavioral Assays to the Bench
How do you reliably quantify behavior? Zantiks CEO Dr. Bill Budenberg Explains
Industry Insight
Novel Neuromuscular Junction Model Benefits Drug Discovery
The first functional stem-cell derived neuromuscular junction model has recently been licensed, which could help the quest to develop new drugs to treat associated neurodegenerative diseases. We caught up with James Hickman, CSO, Hesperos, to learn more about the model, and some of the benefits it brings.
Industry Insight
Harnessing Stem Cells for Blood Vessel Regeneration
Vascugen recently announced that it had licensed stem cell technology for blood vessel regeneration at IU School of Medicine, which could lead to new treatment options for patients suffering from Peripheral Artery Disease and Critical Limb Ischemia. We caught up with Carter Cliff, CEO, Vascugen to learn more about the technology and the science behind it.
Industry Insight
Flow Technology Innovations Driving Drug Discovery Forward
Flow chemistry is playing an increasingly prominent role in drug discovery, enabling those in the field to streamline chemistry discovery and development efforts. Finding ways to reduce the time it takes to generate validated small-molecule compounds would be highly advantageous – which is exactly why scientists at Abbvie developed SWIFT.
Industry Insight
A New Generation of Flow Cytometers Advances Multiomics
Flow cytometry allows the analysis of physical and biochemical features of cells. Advances in machine that can characterize and sort cells will allow researchers to look deeper than ever before into the proteome and transcriptome. We talk with Bob Balderas, VP Market Development at BD on how the cutting-edge machines like the FACSymphony S6 cell sorter incorporate new technology and advance multiomics research.
Industry Insight
Deploying Cloud Technologies to Fight Pediatric Cancer
The St. Jude Cloud is a recently-launched online data-sharing and collaboration platform that provides access to the largest public repository of pediatric cancer genomics data. We caught up with Jinghui Zhang, PhD, from St. Jude Children’s Research Hospital to discuss the cloud and its impact on pediatric research.
Industry Insight
How Native MS and Charge Algorithms Can Improve Protein Analysis
Native Mass Spectrometry (MS) can be used to examine proteins in their natural, folded forms. In this blog, Marshall Bern, Ph.D., the Vice President of Research and Co-Founder of Protein Metrics, discusses how advances in this technique are being paired with cutting-edge charge deconvolution algorithms to improve analysis of antibodies and plasma glycoproteins.
Advertisement